Psoriasis drug trial for Hard-to-Treat areas ends early
NCT ID NCT06042920
First seen Apr 18, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study tested the drug deucravacitinib in 130 adults with psoriasis on their palms, soles, and genitals. The goal was to see if it could safely improve skin symptoms like redness and scaling. The trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENITAL PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Local Institution - 0001
Winston-Salem, North Carolina, 27157, United States
-
Local Institution - 0002
New York, New York, 10003, United States
-
Local Institution - 0004
Santa Monica, California, 90404, United States
-
Local Institution - 0005
East Windsor, New Jersey, 08520-2505, United States
-
Local Institution - 0007
Norfolk, Virginia, 23502-3933, United States
-
Local Institution - 0008
New York, New York, 10075, United States
-
Local Institution - 0009
Los Angeles, California, 90045-3606, United States
-
Local Institution - 0010
Houston, Texas, 77004, United States
-
Local Institution - 0012
Detroit, Michigan, 48202-3141, United States
-
Local Institution - 0015
Fountain Valley, California, 92708, United States
-
Local Institution - 0029
Rockville, Maryland, 20850-6243, United States
-
Local Institution - 0033
Mill Creek, Washington, 98012-1797, United States
-
Local Institution - 0034
Ciudad Autonoma Buenos Aires, C, C1425DKG, Argentina
-
Local Institution - 0037
Ciudad Autónoma Buenos Aires, B, C1428DZF, Argentina
-
Local Institution - 0042
Rosario, S, 2000, Argentina
-
Local Institution - 0043
Ciudad Autónoma Buenos Aires, B, 1425, Argentina
-
Local Institution - 0050
Phoenix, Arizona, 85006-2722, United States
-
Local Institution - 0052
Indianapolis, Indiana, 46250, United States
-
Local Institution - 0053
Plainfield, Indiana, 46168-2792, United States
-
Local Institution - 0054
Montreal, Quebec, H2X 2V1, Canada
-
Local Institution - 0055
Mayfield Heights, Ohio, 44124-4005, United States
-
Local Institution - 0056
Pittsburgh, Pennsylvania, 15213-3403, United States
-
Local Institution - 0057
Skokie, Illinois, 60077-1049, United States
-
Local Institution - 0058
Newmarket, Ontario, L3Y 5G8, Canada
-
Local Institution - 0059
Québec, Quebec, G1W 4R4, Canada
-
Local Institution - 0060
Toronto, Ontario, M3B 0A7, Canada
-
Local Institution - 0061
Saint-Jérôme, Quebec, J7Z 7E2, Canada
-
Local Institution - 0062
New York, New York, 10128, United States
-
Local Institution - 0064
Saskatoon, Saskatchewan, S7K 2C1, Canada
-
Local Institution - 0065
Montreal, Quebec, H1Y 3L1, Canada
-
Local Institution - 0066
Boardman, Ohio, 44512, United States
Conditions
Explore the condition pages connected to this study.